Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Siatskas

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Molecular Medicine|September 15, 2009
Stem cell and gene therapeutic strategies for the treatment of multiple sclerosisChristopher Siatskas, Claude C Bernard
Stem Cell Research & Therapy|January 17, 2016
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?Maha M Bakhuraysah, Christopher Siatskas, Steven Petratos
Journal of Autoimmunity|May 28, 2008
The promise of stem cell and regenerative therapies for multiple sclerosisNatalie Payne, Christopher Siatskas, Claude C A Bernard
Current Stem Cell Research & Therapy|October 20, 2010
The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosisNatalie Payne, Christopher Siatskas, Adele Barnard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 4, 2005
Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanismsChristopher Siatskas, John Underwood, Ali Ramezani, et al.
Stem Cell Reviews and Reports|July 29, 2010
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!Christopher Siatskas, Natalie L Payne, Martin A Short, et al.
Transfusion|March 5, 2004
Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34+ cellsStephen L Smith, Joseph Kiss, Christopher Siatskas, et al.
Current Gene Therapy|February 16, 2006
Gene therapy strategies towards immune tolerance to treat the autoimmune diseasesChristopher Siatskas, James Chan, Judith Field, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Haematopoietic stem cell gene therapy to treat autoimmune diseaseFrank Alderuccio, Christopher Siatskas, James Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Lentivirally transduced recipient-derived dendritic cells serve to ex vivo expand functional FcRgamma-sufficient double-negative regulatory T cellsChristopher W Thomson, Miriam E Mossoba, Christopher Siatskas, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Molecular Medicine|September 15, 2009
Stem cell and gene therapeutic strategies for the treatment of multiple sclerosisChristopher Siatskas, Claude C Bernard
Stem Cell Research & Therapy|January 17, 2016
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?Maha M Bakhuraysah, Christopher Siatskas, Steven Petratos
Journal of Autoimmunity|May 28, 2008
The promise of stem cell and regenerative therapies for multiple sclerosisNatalie Payne, Christopher Siatskas, Claude C A Bernard
Current Stem Cell Research & Therapy|October 20, 2010
The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosisNatalie Payne, Christopher Siatskas, Adele Barnard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 4, 2005
Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanismsChristopher Siatskas, John Underwood, Ali Ramezani, et al.
Stem Cell Reviews and Reports|July 29, 2010
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!Christopher Siatskas, Natalie L Payne, Martin A Short, et al.
Transfusion|March 5, 2004
Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34+ cellsStephen L Smith, Joseph Kiss, Christopher Siatskas, et al.
Current Gene Therapy|February 16, 2006
Gene therapy strategies towards immune tolerance to treat the autoimmune diseasesChristopher Siatskas, James Chan, Judith Field, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Haematopoietic stem cell gene therapy to treat autoimmune diseaseFrank Alderuccio, Christopher Siatskas, James Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Lentivirally transduced recipient-derived dendritic cells serve to ex vivo expand functional FcRgamma-sufficient double-negative regulatory T cellsChristopher W Thomson, Miriam E Mossoba, Christopher Siatskas, et al.
Pageof 4